A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers

• Himisha Beltran
• , Clara Oromendia
• , Daniel C. Danila
• , Bruce Montgomery
• , Christopher Hoimes
• , Russell Z. Szmulewitz
• , Ulka Vaishampayan
• , Andrew J. Armstrong
• , Mark Stein
• , Jacek Pinski
• , Juan M. Mosquera
• , Verena Sailer
• , Rohan Bareja
• , Alessandro Romanel
• , Naveen Gumpeni
• , Andrea Sboner
• , Etienne Dardenne
• , Loredana Puca
• , Davide Prandi
• , Mark A. Rubin
• , Howard I. Scher
• , David S. Rickman
• , Francesca Demichelis
• , David M. Nanus
• , Karla V. Ballman
• , Scott T. Tagawa